Biomerica (BMRA) Receivables - Net (2011 - 2026)

Biomerica (BMRA) has 16 years of Receivables - Net data on file, last reported at $941000.0 in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net fell 25.79% year-over-year to $941000.0; the trailing twelve-month figure through Feb 2026 stood at $941000.0 (down 25.79% YoY), and the FY2025 full-year result was $731000.0, down 22.81% from the prior year.
• Receivables - Net declined to $941000.0 in Q1 2026, from $947000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.6 million in Q3 2024 to a low of $722000.0 in Q2 2023.
• A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Receivables - Net.
• Peak annual rise in Receivables - Net reached 70.29% in 2022, while the deepest fall reached 46.81% in 2022.
• Tracing BMRA's Receivables - Net over 5 years: stood at $1.4 million in 2022, then decreased by 22.23% to $1.1 million in 2023, then gained by 24.27% to $1.3 million in 2024, then declined by 28.58% to $947000.0 in 2025, then retreated by 0.63% to $941000.0 in 2026.
• Business Quant data shows BMRA's Receivables - Net at $941000.0 in Q1 2026, $947000.0 in Q4 2025, and $1.2 million in Q3 2025.